Sibofimloc (Antibiotic-202) is a first-in-class, gut-restricted, orally active FimH adhesion inhibitor extracted from patent WO2014100158A1, Compound Example 202. Sibofimloc has anti-bacterial infective activity. Sibofimloc is developed for inflammatory bowel disease (IBD)[1][2].
Molecular Weight:
649.68
Purity:
99.70
CAS Number:
[1616113-45-1]
Formula:
C35H39NO11
Target:
Antibiotic,Bacterial
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
